Study Title: The Back Pain Consortium Research Program (The BACPAC Study) NCT: NCT04870957 IRB Document Version Approval Date: BPC 157 Data: Promising, But Not Proven In Humans, Early animal studies suggest BPC 157 may reduce pain behaviors in inflammatory and non inflammatory models, including reduced allodynia. But this Conventional Antiarrhythmics Class IIV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats Journal of Orthopaedic Surgery and Research Springer Nature Link